nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—CYP3A4—Temozolomide—brain cancer	0.306	0.486	CbGbCtD
Desvenlafaxine—CYP3A4—Lomustine—brain cancer	0.26	0.414	CbGbCtD
Desvenlafaxine—CYP3A4—Etoposide—brain cancer	0.0629	0.1	CbGbCtD
Desvenlafaxine—Haemorrhagic disorder—Procarbazine—brain cancer	0.0235	0.0717	CcSEcCtD
Desvenlafaxine—Venlafaxine—CYP2C9—brain cancer	0.013	1	CrCbGaD
Desvenlafaxine—Interstitial lung disease—Carmustine—brain cancer	0.00524	0.016	CcSEcCtD
Desvenlafaxine—Interstitial lung disease—Temozolomide—brain cancer	0.00506	0.0155	CcSEcCtD
Desvenlafaxine—Extrapyramidal disorder—Temozolomide—brain cancer	0.00476	0.0145	CcSEcCtD
Desvenlafaxine—SLC6A4—ganglion—brain cancer	0.0043	0.14	CbGeAlD
Desvenlafaxine—Alopecia—Lomustine—brain cancer	0.00414	0.0127	CcSEcCtD
Desvenlafaxine—Disturbance in attention—Temozolomide—brain cancer	0.00414	0.0126	CcSEcCtD
Desvenlafaxine—Interstitial lung disease—Etoposide—brain cancer	0.00405	0.0124	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.00388	0.0118	CcSEcCtD
Desvenlafaxine—SLC6A2—ganglion—brain cancer	0.00379	0.123	CbGeAlD
Desvenlafaxine—Photosensitivity reaction—Procarbazine—brain cancer	0.0034	0.0104	CcSEcCtD
Desvenlafaxine—SLC6A4—hindbrain—brain cancer	0.00326	0.106	CbGeAlD
Desvenlafaxine—Epistaxis—Procarbazine—brain cancer	0.00313	0.00955	CcSEcCtD
Desvenlafaxine—Breast disorder—Hydroxyurea—brain cancer	0.00301	0.00919	CcSEcCtD
Desvenlafaxine—Hallucination—Procarbazine—brain cancer	0.00296	0.00905	CcSEcCtD
Desvenlafaxine—Decreased appetite—Lomustine—brain cancer	0.0029	0.00884	CcSEcCtD
Desvenlafaxine—Hot flush—Temozolomide—brain cancer	0.00278	0.00849	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Temozolomide—brain cancer	0.00276	0.00842	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Carmustine—brain cancer	0.0027	0.00826	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.00269	0.00822	CcSEcCtD
Desvenlafaxine—Chills—Procarbazine—brain cancer	0.00267	0.00816	CcSEcCtD
Desvenlafaxine—Alopecia—Procarbazine—brain cancer	0.00263	0.00803	CcSEcCtD
Desvenlafaxine—Weight increased—Hydroxyurea—brain cancer	0.00262	0.008	CcSEcCtD
Desvenlafaxine—Tension—Procarbazine—brain cancer	0.00254	0.00777	CcSEcCtD
Desvenlafaxine—Nervousness—Procarbazine—brain cancer	0.00252	0.00769	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Carmustine—brain cancer	0.00249	0.00759	CcSEcCtD
Desvenlafaxine—Tremor—Procarbazine—brain cancer	0.00243	0.00742	CcSEcCtD
Desvenlafaxine—Breast disorder—Temozolomide—brain cancer	0.00235	0.00718	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00234	0.00716	CcSEcCtD
Desvenlafaxine—Syncope—Procarbazine—brain cancer	0.00232	0.0071	CcSEcCtD
Desvenlafaxine—Hallucination—Hydroxyurea—brain cancer	0.00229	0.007	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Procarbazine—brain cancer	0.00228	0.00696	CcSEcCtD
Desvenlafaxine—Convulsion—Procarbazine—brain cancer	0.00225	0.00686	CcSEcCtD
Desvenlafaxine—Hypertension—Procarbazine—brain cancer	0.00224	0.00683	CcSEcCtD
Desvenlafaxine—Anxiety—Procarbazine—brain cancer	0.0022	0.00671	CcSEcCtD
Desvenlafaxine—Dry mouth—Procarbazine—brain cancer	0.00216	0.00659	CcSEcCtD
Desvenlafaxine—Vomiting—Lomustine—brain cancer	0.00212	0.00647	CcSEcCtD
Desvenlafaxine—Angiopathy—Hydroxyurea—brain cancer	0.00209	0.00638	CcSEcCtD
Desvenlafaxine—Shock—Procarbazine—brain cancer	0.00208	0.00636	CcSEcCtD
Desvenlafaxine—Erectile dysfunction—Temozolomide—brain cancer	0.00207	0.00633	CcSEcCtD
Desvenlafaxine—Chills—Hydroxyurea—brain cancer	0.00207	0.00631	CcSEcCtD
Desvenlafaxine—Tachycardia—Procarbazine—brain cancer	0.00206	0.0063	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Temozolomide—brain cancer	0.00205	0.00627	CcSEcCtD
Desvenlafaxine—Weight increased—Temozolomide—brain cancer	0.00205	0.00625	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Procarbazine—brain cancer	0.00204	0.00624	CcSEcCtD
Desvenlafaxine—Alopecia—Hydroxyurea—brain cancer	0.00204	0.00622	CcSEcCtD
Desvenlafaxine—Weight decreased—Temozolomide—brain cancer	0.00203	0.00621	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00199	0.00607	CcSEcCtD
Desvenlafaxine—Nausea—Lomustine—brain cancer	0.00198	0.00604	CcSEcCtD
Desvenlafaxine—Insomnia—Procarbazine—brain cancer	0.00191	0.00584	CcSEcCtD
Desvenlafaxine—Paraesthesia—Procarbazine—brain cancer	0.0019	0.0058	CcSEcCtD
Desvenlafaxine—Somnolence—Procarbazine—brain cancer	0.00188	0.00574	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00187	0.00573	CcSEcCtD
Desvenlafaxine—SLC6A4—brainstem—brain cancer	0.00187	0.0608	CbGeAlD
Desvenlafaxine—Hallucination—Carmustine—brain cancer	0.00185	0.00566	CcSEcCtD
Desvenlafaxine—Decreased appetite—Procarbazine—brain cancer	0.00184	0.00562	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Carmustine—brain cancer	0.00183	0.00559	CcSEcCtD
Desvenlafaxine—Fatigue—Procarbazine—brain cancer	0.00182	0.00557	CcSEcCtD
Desvenlafaxine—Constipation—Procarbazine—brain cancer	0.00181	0.00552	CcSEcCtD
Desvenlafaxine—Hallucination—Temozolomide—brain cancer	0.00179	0.00547	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Temozolomide—brain cancer	0.00178	0.00543	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Temozolomide—brain cancer	0.00177	0.0054	CcSEcCtD
Desvenlafaxine—Urethral disorder—Temozolomide—brain cancer	0.00176	0.00539	CcSEcCtD
Desvenlafaxine—Eye disorder—Carmustine—brain cancer	0.00174	0.00532	CcSEcCtD
Desvenlafaxine—Convulsion—Hydroxyurea—brain cancer	0.00174	0.00531	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Temozolomide—brain cancer	0.0017	0.0052	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.0017	0.00518	CcSEcCtD
Desvenlafaxine—Eye disorder—Temozolomide—brain cancer	0.00168	0.00514	CcSEcCtD
Desvenlafaxine—Tinnitus—Temozolomide—brain cancer	0.00168	0.00513	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Temozolomide—brain cancer	0.00167	0.0051	CcSEcCtD
Desvenlafaxine—SLC6A4—telencephalon—brain cancer	0.00166	0.0539	CbGeAlD
Desvenlafaxine—Alopecia—Carmustine—brain cancer	0.00165	0.00503	CcSEcCtD
Desvenlafaxine—SLC6A2—brainstem—brain cancer	0.00165	0.0535	CbGeAlD
Desvenlafaxine—Angiopathy—Temozolomide—brain cancer	0.00163	0.00499	CcSEcCtD
Desvenlafaxine—Mental disorder—Carmustine—brain cancer	0.00163	0.00498	CcSEcCtD
Desvenlafaxine—Immune system disorder—Temozolomide—brain cancer	0.00163	0.00497	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Temozolomide—brain cancer	0.00162	0.00495	CcSEcCtD
Desvenlafaxine—Malnutrition—Carmustine—brain cancer	0.00162	0.00495	CcSEcCtD
Desvenlafaxine—Chills—Temozolomide—brain cancer	0.00162	0.00493	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Hydroxyurea—brain cancer	0.00161	0.0049	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00159	0.00486	CcSEcCtD
Desvenlafaxine—Alopecia—Temozolomide—brain cancer	0.00159	0.00486	CcSEcCtD
Desvenlafaxine—Skin disorder—Hydroxyurea—brain cancer	0.00159	0.00486	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Etoposide—brain cancer	0.00158	0.00483	CcSEcCtD
Desvenlafaxine—Mental disorder—Temozolomide—brain cancer	0.00158	0.00482	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Etoposide—brain cancer	0.00157	0.0048	CcSEcCtD
Desvenlafaxine—Malnutrition—Temozolomide—brain cancer	0.00157	0.00479	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Procarbazine—brain cancer	0.00156	0.00476	CcSEcCtD
Desvenlafaxine—Dysgeusia—Temozolomide—brain cancer	0.00153	0.00469	CcSEcCtD
Desvenlafaxine—Vision blurred—Carmustine—brain cancer	0.00153	0.00467	CcSEcCtD
Desvenlafaxine—Tremor—Carmustine—brain cancer	0.00152	0.00464	CcSEcCtD
Desvenlafaxine—Asthenia—Procarbazine—brain cancer	0.00152	0.00463	CcSEcCtD
Desvenlafaxine—Vision blurred—Temozolomide—brain cancer	0.00148	0.00451	CcSEcCtD
Desvenlafaxine—Tremor—Temozolomide—brain cancer	0.00147	0.00448	CcSEcCtD
Desvenlafaxine—SLC6A2—telencephalon—brain cancer	0.00146	0.0475	CbGeAlD
Desvenlafaxine—Somnolence—Hydroxyurea—brain cancer	0.00146	0.00444	CcSEcCtD
Desvenlafaxine—Diarrhoea—Procarbazine—brain cancer	0.00145	0.00442	CcSEcCtD
Desvenlafaxine—Angioedema—Temozolomide—brain cancer	0.00143	0.00437	CcSEcCtD
Desvenlafaxine—Decreased appetite—Hydroxyurea—brain cancer	0.00142	0.00435	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Etoposide—brain cancer	0.00142	0.00434	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00141	0.00432	CcSEcCtD
Desvenlafaxine—Urethral disorder—Etoposide—brain cancer	0.00141	0.00431	CcSEcCtD
Desvenlafaxine—Fatigue—Hydroxyurea—brain cancer	0.00141	0.00431	CcSEcCtD
Desvenlafaxine—Vertigo—Temozolomide—brain cancer	0.00141	0.0043	CcSEcCtD
Desvenlafaxine—Convulsion—Carmustine—brain cancer	0.0014	0.00429	CcSEcCtD
Desvenlafaxine—Hypertension—Carmustine—brain cancer	0.0014	0.00428	CcSEcCtD
Desvenlafaxine—Constipation—Hydroxyurea—brain cancer	0.0014	0.00428	CcSEcCtD
Desvenlafaxine—Dizziness—Procarbazine—brain cancer	0.0014	0.00427	CcSEcCtD
Desvenlafaxine—Palpitations—Temozolomide—brain cancer	0.00138	0.00423	CcSEcCtD
Desvenlafaxine—Anxiety—Carmustine—brain cancer	0.00138	0.0042	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Etoposide—brain cancer	0.00136	0.00416	CcSEcCtD
Desvenlafaxine—Convulsion—Temozolomide—brain cancer	0.00136	0.00415	CcSEcCtD
Desvenlafaxine—Hypertension—Temozolomide—brain cancer	0.00135	0.00413	CcSEcCtD
Desvenlafaxine—Eye disorder—Etoposide—brain cancer	0.00135	0.00411	CcSEcCtD
Desvenlafaxine—Vomiting—Procarbazine—brain cancer	0.00134	0.00411	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Etoposide—brain cancer	0.00134	0.00408	CcSEcCtD
Desvenlafaxine—Rash—Procarbazine—brain cancer	0.00133	0.00407	CcSEcCtD
Desvenlafaxine—Dermatitis—Procarbazine—brain cancer	0.00133	0.00407	CcSEcCtD
Desvenlafaxine—Anxiety—Temozolomide—brain cancer	0.00133	0.00406	CcSEcCtD
Desvenlafaxine—Headache—Procarbazine—brain cancer	0.00133	0.00405	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00132	0.00405	CcSEcCtD
Desvenlafaxine—Angiopathy—Etoposide—brain cancer	0.00131	0.00399	CcSEcCtD
Desvenlafaxine—Dry mouth—Temozolomide—brain cancer	0.0013	0.00398	CcSEcCtD
Desvenlafaxine—Immune system disorder—Etoposide—brain cancer	0.0013	0.00397	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Etoposide—brain cancer	0.0013	0.00396	CcSEcCtD
Desvenlafaxine—Chills—Etoposide—brain cancer	0.00129	0.00395	CcSEcCtD
Desvenlafaxine—Tachycardia—Carmustine—brain cancer	0.00129	0.00394	CcSEcCtD
Desvenlafaxine—Alopecia—Etoposide—brain cancer	0.00127	0.00389	CcSEcCtD
Desvenlafaxine—Nausea—Procarbazine—brain cancer	0.00126	0.00384	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Temozolomide—brain cancer	0.00125	0.00383	CcSEcCtD
Desvenlafaxine—Skin disorder—Temozolomide—brain cancer	0.00124	0.00379	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Temozolomide—brain cancer	0.00124	0.00378	CcSEcCtD
Desvenlafaxine—Dysgeusia—Etoposide—brain cancer	0.00123	0.00375	CcSEcCtD
Desvenlafaxine—SLC6A2—gonad—brain cancer	0.00122	0.0396	CbGeAlD
Desvenlafaxine—Hypersensitivity—Hydroxyurea—brain cancer	0.00121	0.00368	CcSEcCtD
Desvenlafaxine—Insomnia—Carmustine—brain cancer	0.0012	0.00366	CcSEcCtD
Desvenlafaxine—SLC6A4—midbrain—brain cancer	0.00119	0.0387	CbGeAlD
Desvenlafaxine—Paraesthesia—Carmustine—brain cancer	0.00119	0.00363	CcSEcCtD
Desvenlafaxine—Somnolence—Carmustine—brain cancer	0.00118	0.00359	CcSEcCtD
Desvenlafaxine—Asthenia—Hydroxyurea—brain cancer	0.00117	0.00359	CcSEcCtD
Desvenlafaxine—SLC6A4—spinal cord—brain cancer	0.00116	0.0378	CbGeAlD
Desvenlafaxine—Insomnia—Temozolomide—brain cancer	0.00116	0.00353	CcSEcCtD
Desvenlafaxine—Decreased appetite—Carmustine—brain cancer	0.00115	0.00351	CcSEcCtD
Desvenlafaxine—Paraesthesia—Temozolomide—brain cancer	0.00115	0.00351	CcSEcCtD
Desvenlafaxine—SLC6A2—medulla oblongata—brain cancer	0.00115	0.0373	CbGeAlD
Desvenlafaxine—Gastrointestinal disorder—Carmustine—brain cancer	0.00114	0.00349	CcSEcCtD
Desvenlafaxine—Somnolence—Temozolomide—brain cancer	0.00114	0.00347	CcSEcCtD
Desvenlafaxine—Constipation—Carmustine—brain cancer	0.00113	0.00346	CcSEcCtD
Desvenlafaxine—Vertigo—Etoposide—brain cancer	0.00113	0.00344	CcSEcCtD
Desvenlafaxine—Diarrhoea—Hydroxyurea—brain cancer	0.00112	0.00342	CcSEcCtD
Desvenlafaxine—Decreased appetite—Temozolomide—brain cancer	0.00111	0.00339	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Temozolomide—brain cancer	0.0011	0.00337	CcSEcCtD
Desvenlafaxine—Fatigue—Temozolomide—brain cancer	0.0011	0.00337	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Etoposide—brain cancer	0.0011	0.00337	CcSEcCtD
Desvenlafaxine—Constipation—Temozolomide—brain cancer	0.00109	0.00334	CcSEcCtD
Desvenlafaxine—Convulsion—Etoposide—brain cancer	0.00109	0.00332	CcSEcCtD
Desvenlafaxine—Hypertension—Etoposide—brain cancer	0.00108	0.00331	CcSEcCtD
Desvenlafaxine—Dizziness—Hydroxyurea—brain cancer	0.00108	0.00331	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00106	0.00324	CcSEcCtD
Desvenlafaxine—SLC6A4—endocrine gland—brain cancer	0.00105	0.034	CbGeAlD
Desvenlafaxine—Vomiting—Hydroxyurea—brain cancer	0.00104	0.00318	CcSEcCtD
Desvenlafaxine—SLC6A4—head—brain cancer	0.00103	0.0336	CbGeAlD
Desvenlafaxine—Rash—Hydroxyurea—brain cancer	0.00103	0.00315	CcSEcCtD
Desvenlafaxine—Dermatitis—Hydroxyurea—brain cancer	0.00103	0.00315	CcSEcCtD
Desvenlafaxine—Headache—Hydroxyurea—brain cancer	0.00103	0.00313	CcSEcCtD
Desvenlafaxine—Tachycardia—Etoposide—brain cancer	0.000999	0.00305	CcSEcCtD
Desvenlafaxine—Skin disorder—Etoposide—brain cancer	0.000994	0.00304	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Etoposide—brain cancer	0.000989	0.00302	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Carmustine—brain cancer	0.000975	0.00298	CcSEcCtD
Desvenlafaxine—Nausea—Hydroxyurea—brain cancer	0.000972	0.00297	CcSEcCtD
Desvenlafaxine—Asthenia—Carmustine—brain cancer	0.000949	0.0029	CcSEcCtD
Desvenlafaxine—SLC6A4—central nervous system—brain cancer	0.000943	0.0307	CbGeAlD
Desvenlafaxine—Hypersensitivity—Temozolomide—brain cancer	0.000942	0.00288	CcSEcCtD
Desvenlafaxine—SLC6A2—endocrine gland—brain cancer	0.000921	0.0299	CbGeAlD
Desvenlafaxine—Paraesthesia—Etoposide—brain cancer	0.000919	0.00281	CcSEcCtD
Desvenlafaxine—Asthenia—Temozolomide—brain cancer	0.000918	0.0028	CcSEcCtD
Desvenlafaxine—Somnolence—Etoposide—brain cancer	0.00091	0.00278	CcSEcCtD
Desvenlafaxine—SLC6A2—head—brain cancer	0.000909	0.0296	CbGeAlD
Desvenlafaxine—Diarrhoea—Carmustine—brain cancer	0.000905	0.00277	CcSEcCtD
Desvenlafaxine—Decreased appetite—Etoposide—brain cancer	0.00089	0.00272	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Etoposide—brain cancer	0.000883	0.0027	CcSEcCtD
Desvenlafaxine—Fatigue—Etoposide—brain cancer	0.000882	0.00269	CcSEcCtD
Desvenlafaxine—Dizziness—Carmustine—brain cancer	0.000875	0.00267	CcSEcCtD
Desvenlafaxine—Constipation—Etoposide—brain cancer	0.000875	0.00267	CcSEcCtD
Desvenlafaxine—Diarrhoea—Temozolomide—brain cancer	0.000875	0.00267	CcSEcCtD
Desvenlafaxine—Dizziness—Temozolomide—brain cancer	0.000846	0.00258	CcSEcCtD
Desvenlafaxine—Vomiting—Carmustine—brain cancer	0.000841	0.00257	CcSEcCtD
Desvenlafaxine—Rash—Carmustine—brain cancer	0.000834	0.00255	CcSEcCtD
Desvenlafaxine—Dermatitis—Carmustine—brain cancer	0.000834	0.00255	CcSEcCtD
Desvenlafaxine—SLC6A2—central nervous system—brain cancer	0.00083	0.027	CbGeAlD
Desvenlafaxine—Headache—Carmustine—brain cancer	0.000829	0.00253	CcSEcCtD
Desvenlafaxine—Vomiting—Temozolomide—brain cancer	0.000813	0.00248	CcSEcCtD
Desvenlafaxine—Rash—Temozolomide—brain cancer	0.000806	0.00246	CcSEcCtD
Desvenlafaxine—Dermatitis—Temozolomide—brain cancer	0.000806	0.00246	CcSEcCtD
Desvenlafaxine—Headache—Temozolomide—brain cancer	0.000801	0.00245	CcSEcCtD
Desvenlafaxine—Nausea—Carmustine—brain cancer	0.000786	0.0024	CcSEcCtD
Desvenlafaxine—Nausea—Temozolomide—brain cancer	0.00076	0.00232	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Etoposide—brain cancer	0.000754	0.0023	CcSEcCtD
Desvenlafaxine—SLC6A4—brain—brain cancer	0.000749	0.0243	CbGeAlD
Desvenlafaxine—Asthenia—Etoposide—brain cancer	0.000734	0.00224	CcSEcCtD
Desvenlafaxine—Diarrhoea—Etoposide—brain cancer	0.0007	0.00214	CcSEcCtD
Desvenlafaxine—Dizziness—Etoposide—brain cancer	0.000677	0.00207	CcSEcCtD
Desvenlafaxine—SLC6A2—brain—brain cancer	0.000659	0.0214	CbGeAlD
Desvenlafaxine—Vomiting—Etoposide—brain cancer	0.000651	0.00199	CcSEcCtD
Desvenlafaxine—Rash—Etoposide—brain cancer	0.000645	0.00197	CcSEcCtD
Desvenlafaxine—Dermatitis—Etoposide—brain cancer	0.000645	0.00197	CcSEcCtD
Desvenlafaxine—Headache—Etoposide—brain cancer	0.000641	0.00196	CcSEcCtD
Desvenlafaxine—Nausea—Etoposide—brain cancer	0.000608	0.00186	CcSEcCtD
Desvenlafaxine—CYP3A4—endocrine gland—brain cancer	0.000513	0.0167	CbGeAlD
Desvenlafaxine—CYP3A4—central nervous system—brain cancer	0.000462	0.015	CbGeAlD
